Key facts
- This page summarizes John Peter Mclaughlin's Form 4 filing for LENSAR, Inc. (LNSR).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2022, 21:27.
John Peter Mclaughlin - 25 May 2022 Form 4 Insider Report for LENSAR, Inc. (LNSR)
- Reporting relationship
- Director
- Issuer ticker
- LNSR
- Reported as of
- 25 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 May 2022, 21:27:42 UTC
- Prior SEC filing
- 22 Jun 2021
- Next SEC filing
- 30 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas R. Staab, II, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Peter Mclaughlin filed Form 4 for LENSAR, Inc. (LNSR) on 27 May 2022.
Change
- Previous filing in this sequence was filed on 22 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LNSR
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,285
- Change %
- +11%
- Price
- $0.000000
- Shares after
- 44,343
- Date
- 25 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LNSR
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +15,616
- Change %
- Price
- $0.000000
- Shares after
- 15,616
- Date
- 25 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,616
- Exercise price
- $7.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer
Footnote F2
Includes 40,058 shares of the Issuer's common stock received by the Reporting Person in connection with the October 1, 2020 spin-off (the "Spin-Off Date") of the Issuer from PDL BioPharma, Inc. ("PDL") on account of his ownership of shares of PDL common stock.
Footnote F3
The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.